Anticholinergic Use Is a Major Risk Factor for Dysphonia. (October 2015)

• Record Type: Journal Article
• Authors: Haft, Sunny; Farquhar, Douglas; Carey, Ryan; Mirza, Natasha
• Is Part Of: Annals of otology, rhinology & laryngology. Volume 124:Number 10(2015:Oct.)
• Page Start: 797
• Page End: 802
• Publication Date: 2015-10
• Subjects: anticholinergic -- dysphonia -- GRBAS -- hoarseness -- laryngitis -- medications -- RSI -- sicca -- VHI -- voice; Otolaryngology -- Periodicals; 617.51
• DOI: 10.1177/0003489415585867
• Languages: English
• ISSNs: 0003-4894

Abstract

Objective: We hypothesize that many cases of dysphonia of unclear etiology are a form of sicca caused by anticholinergic medication use, and we aim to determine their association. Study Design: This was a cross-sectional study conducted over a 6-month time period. Participants were drawn from a tertiary care laryngology practice within an academic institution. Methods: One hundred forty-nine patients met inclusion criteria. Patients rated the symptom of chronic hoarseness; scores were compared with participants' medication lists, comorbidities, age, and sex, and a multivariate logistic regression model was developed. Significance was set at P < .05. As a secondary analysis, participants rated a variety of other symptoms using the Voice Handicap Index-10, Reflux Symptom Index, and the GRBAS scale, which were likewise compared to anticholinergic use. Results: Any patient taking at least 1 anticholinergic medication had a 2.32 increased odds ( P = .03) of experiencing hoarseness. If the patient was taking 2 or more anticholinergic medications, those odds rose to 4.52 ( P = .009). Conclusion: This is the first study, to our knowledge, that implicates medication use as a major risk factor for dysphonia of unclear etiology. An awareness of this association is invaluable when attributing cause to hoarseness and when considering treatment options.